Skip to main content

Table 1 Clinicopathological characteristics of the cervical cancer patients

From: RESOLVE-DWI-based deep learning nomogram for prediction of normal-sized lymph node metastasis in cervical cancer: a preliminary study

 

Development cohort

Test cohort

Non-metastasis (n = 96)

Metastasis (n = 30)

P-value

Non-metastasis (n = 32)

Metastasis (n = 11)

P-value

Age (years)

50.45 ± 10.59

52.57 ± 9.54

0.330

53.16 ± 9.73

50.64 ± 7.19

0.436

Tumor size

  

0.008

  

0.035

 < 2 cm

23

2

 

9

0

 

 2–4 cm

44

10

 

17

5

 

 > 4 cm

29

18

 

6

6

 

FIGO stage

  

0.219

  

0.278

 IB

68

17

 

27

7

 

 IIA

24

10

 

4

3

 

 IIB

4

3

 

1

1

 

ADC value (×10− 3mm2/s)

0.96 ± 0.14

0.89 ± 0.12

0.023

0.98 ± 0.14

0.86 ± 0.11

0.015

SCCa level (ng/mL)

4.51 ± 7.38

11.32 ± 13.80

0.001

3.93 ± 4.76

8.79 ± 6.46

0.007

  1. FIGO International Federation of Gynecology and Obstetrics; ADC Apparent diffusion coefficient; SCCa Squamous cell carcinoma antigen
  2. P < 0.05 indicates statistically significant